Brainstorm Cell Therapeutics | BCLI - Le Bénéfice D'Exploitation

Prix De L'Action
0.88
Variation Quotidienne
-0.04 -4.66%
Mensuellement
-2.22%
Annuel
13.39%
Q2 Prévisions
0.90




Le Bénéfice D'Exploitation Changement Date
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Biogen USD 659.6M 192.2M 2025-09
Brainstorm Cell Therapeutics USD -2.24M 197K 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD 56.04M 63.93M 2025-12
CSL USD 2.64B 1.97B 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Mesoblast USD -30.96M 11.14M 2025-12